11692041

Source:http://linkedlifedata.com/resource/pubmed/id/11692041

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282440, umls-concept:C1442460, umls-concept:C1623117
pubmed:issue	11
pubmed:dateCreated	2001-11-5
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0235266
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1524-4628
pubmed:author	pubmed-author:LydenP DPD
pubmed:issnType	Electronic
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2709-10
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11692041-Brain Ischemia, pubmed-meshheading:11692041-Fibrinolytic Agents, pubmed-meshheading:11692041-Humans, pubmed-meshheading:11692041-Randomized Controlled Trials as Topic, pubmed-meshheading:11692041-Stroke, pubmed-meshheading:11692041-Thrombolytic Therapy, pubmed-meshheading:11692041-Time Factors, pubmed-meshheading:11692041-Tissue Plasminogen Activator
pubmed:year	2001
pubmed:articleTitle	Further randomized controlled trials of tPA within 3 hours are required-not!
pubmed:affiliation	School of Medicine, University of California-San Diego, USA. plyden@ucsd.edu
pubmed:publicationType	Journal Article